Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Sarcoma, Ewing × Melphalan × Clear all

Phase

Phase 1 5 Phase 2 4 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 36 Neoplasms, Plasma Cell 13 Leukemia, Myeloid, Acute 9 Lymphoma 8 Neuroblastoma 7 Lymphoma, Large B-Cell, Diffuse 7 Immunoglobulin Light-chain Amyloidosis 7 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 4 Lymphoma, Large-Cell, Immunoblastic 4 Uveal Melanoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Melanoma 3 Lymphoma, Follicular 3 Amyloidosis 3 Neoplasm Metastasis 2 Lymphoma, Mantle-Cell 2 Leukemia 2 Venentoclax 1 Sarcoma, Ewing 1 Sarcoma 1 Retinoblastoma 1 Rectal Neoplasms 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neoplasms 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myelomonocytic, Acute 1

Interventions

Vincristine 2 Ifosfamide 2 Etoposide 2 Doxorubicin 2 Cyclophosphamide 2 Busulfan 2 treosulfan 1 ganitumab 1 etoposide phosphate 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Temozolomide 1 Radiosurgery 1 Radiation 1 Melphalan 1 Irinotecan 1 FANG vaccine 1 Diphosphonates 1 Dactinomycin 1 Cyproheptadine 1 Congresses as Topic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02063022 2022-09-19

EW-1

Italian Sarcoma Group

Phase 3 Completed

Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon ⚡